Profil
Randall E.
Woods was the founder of Sequel Pharmaceuticals, Inc. founded in 2007, where he held the titles of President, Chief Executive Officer & Director.
Currently, he is the Chief Executive Officer & Director at Tychan Pte Ltd. since 2021, Chairman at Sorbent Therapeutics, Inc. since 2012, and Director at Eden Woods Investments LLC.
Mr. Woods has an undergraduate degree from Ball State University (Indiana) in 1973 and an MBA degree from Western Michigan University.
Aktive Positionen von Randall E. Woods
| Unternehmen | Position | Beginn |
|---|---|---|
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cardiovascular and renal diseases | Vorsitzender | 19.04.2012 |
Eden Woods Investments LLC
Eden Woods Investments LLC Financial ConglomeratesFinance Provides investment services | Direktor/Vorstandsmitglied | - |
Tychan Pte Ltd.
Tychan Pte Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Vorstandsvorsitzender | 01.01.2021 |
Ehemalige bekannte Positionen von Randall E. Woods
| Unternehmen | Position | Ende |
|---|---|---|
| ARENA PHARMACEUTICALS | Direktor/Vorstandsmitglied | 12.06.2020 |
Sequel Pharmaceuticals, Inc.
Sequel Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Engages in the development of cardiovascular drug | Gründer | 01.09.2011 |
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cardiovascular diseases | Vorstandsvorsitzender | 01.09.2007 |
Corvas International, Inc.
Corvas International, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for cardiovascular, cancer, and other diseases | Vorstandsvorsitzender | 01.07.2003 |
Boehringer Mannheim Pharmaceuticals Corp. | Präsident | 01.03.1996 |
Ausbildung von Randall E. Woods
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Corvas International, Inc.
Corvas International, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for cardiovascular, cancer, and other diseases | Health Technology |
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Sophiris Bio, Inc.
Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of urological diseases | Health Technology |
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cardiovascular diseases | Health Technology |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cardiovascular and renal diseases | Health Technology |
Ball State University (Indiana)
Ball State University (Indiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Michigan University
Western Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Commercial Services |
Boehringer Mannheim Pharmaceuticals Corp. | |
Sequel Pharmaceuticals, Inc.
Sequel Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Engages in the development of cardiovascular drug | Retail Trade |
Eden Woods Investments LLC
Eden Woods Investments LLC Financial ConglomeratesFinance Provides investment services | Finance |
Tychan Pte Ltd.
Tychan Pte Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
















